Immunai
PrivateLast Round
Series B
Oct 27, 2021
Est. Valuation
$1B
Total Funding Raised
$295M
Company Overview
Immunai is a biotechnology and bioinformatics company that offers a platform leveraging artificial intelligence to analyze extensive biological datasets for improved understanding of complex diseases and the development of targeted therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunai Comps
Public and private peers based on sector, stage, and business model.
Immunai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 27, 2021 | ||||
| Series A | Feb 11, 2021 | ||||
| Seed | May 14, 2020 |
Key People
Founding team and executive leadership
Immunai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICON | Series B |
| Duquesne Family Office | Series A |
| Koch-ventures.com | Series B |
| Charles and Lynn Schusterman Family Philanthropies | Series A |
| Schusterman Family Investments | Series A |
| Catalio Capital Management | Series A |
| TLV Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
Partnered with Bristol Myers Squibb on a strategic collaboration.
- Jan 12, 2026
Developing an AI model of the immune system called the IDE(TM) engine.
Immunai Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immunai's valuation, stock price, and market status.
